Journal info

6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.


hsa_circ_0067514 suppresses gastric cancer progression and glycolysis via miR-654-3p/LATS2 axis
Authors: Shao-Feng Jiang, Rong-Rong Li
Neoplasma Vol.69, No.5, p.1079–1091, 2022
Price: free access
[View Abstract]

BRAF inhibition promotes ER stress-mediated cell death in uveal melanoma
Authors: Yinu Zhaon, Yue Wang, Li Zhang, Weibin Wang, Thomas J. Fahey, Ke Yao
Neoplasma Vol.69, No.5, p.1070–1078, 2022
Price: free access
[View Abstract]

HSPA5 repressed ferroptosis to promote colorectal cancer development by maintaining GPX4 stability
Authors: Ronglin Wang, Lei Hua, Peixiang Ma, Yang Song, Jie Min, Yongdong Guo, Cheng Yang, Junqiang Li, Haichuan Su
Neoplasma Vol.69, No.5, p.1054–1069, 2022
Price: free access
[View Abstract]

Exosomes from M2 macrophages promoted glycolysis in FaDu cells by inhibiting PDLIM2 expression to stabilize PFKL
Authors: Peng Wang, Guang-Yao Li, Lei Zhou, Huai-Li Jiang, Yue Yang, Hai-Tao Wu
Neoplasma Vol.69, No.5, p.1041–1053, 2022
Price: free access
[View Abstract]

Sodium butyrate inhibits oral squamous cell carcinoma proliferation and invasion by regulating the HDAC1/HSPB7 axis
Authors: Hai-Quan Yue, Peng-Fei Xu, Yi-Dan Guo, Jing Qi, Rui-Min Liu, De-He Li
Neoplasma Vol.69, No.5, p.1029–1040, 2022
Price: free access
[View Abstract]

Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer
Authors: Xiao-Qiang Guo, Yu-Ming Hua
Neoplasma Vol.69, No.5, p.1019–1028, 2022
Price: free access
[View Abstract]

CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity
Authors: Martin Krejci, Zdenek Adam, Marta Krejci, Ludek Pour, Viera Sandecka, Martin Stork
Neoplasma Vol.69, No.5, p.1008–1018, 2022
Price: free access
[View Abstract]

Exploring novel systemic therapies for pancreatic cancer: a review of emerging anti-PD-1/PD-L1 combination therapy
Authors: He Zhang, Xiao-Rui Duan, Lu-Yang Xing, Yu-Xin Jia, Jing-Yi Zhou, Jian-Jun Ma
Neoplasma Vol.69, No.5, p.995–1007, 2022
Price: free access
[View Abstract]

Late effects of childhood cancer recorded at a single outpatient clinic over the course of one year: implications for the follow-up care
Authors: Tomas KEPAK, Hana HRSTKOVA, Viera BAJCIOVA, Vitezslav DUSEK, Marta HOLIKOVA, Lucie STRUBLOVA, Katerina KEPAKOVA
Neoplasma Vol.69, No.4, p.983–992, 2022
Price: free access
[View Abstract]

Clinical outcomes of EGFR-TKIs in advanced squamous cell lung cancer
Authors: Jin-Fei Si, Jing Xiang, Jing-Wen Wei, Yue Hao, Zheng-Bo Song
Neoplasma Vol.69, No.4, p.976–982, 2022
Price: free access
[View Abstract]

NPM1 is a diagnostic and prognostic biomarker associated with the clinicopathological characteristics of gastric cancer
Authors: Chang-An Guo, Xiao-Lu Su, Wen-Jie Wang, Tian-Hong Xia, Xiao-Meng Cao, Shao-Bin Yuan, Wen-An Wang, An Zhang, Hong-Bin Liu
Neoplasma Vol.69, No.4, p.965–975, 2022
Price: free access
[View Abstract]

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry
Authors: Katarína Lešková, Peter Szépe, Tomáš Balhárek, Martina Barthová, Ľuboslava Janáková, Anna Farkašová, Lukáš Plank
Neoplasma Vol.69, No.4, p.957–964, 2022
Price: free access
[View Abstract]

Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers
Authors: Mihaela Ilcheva, Petya Nikolova, Valeria Hadzhiyska, Kiril Mladenov
Neoplasma Vol.69, No.4, p.948–956, 2022
Price: free access
[View Abstract]

Silencing of B7-H4 induces intracellular oxidative stress and inhibits cell viability of breast cancer cells via downregulating PRDX3
Authors: Hao-Chuan Chen, Min Long, Zhao-Wei Gao, Chong Liu, Xia-Nan Wu, Lan Yang, Ke Dong, Hui-Zhong Zhang
Neoplasma Vol.69, No.4, p.940–947, 2022
Price: free access
[View Abstract]

RETRACTION: miR-497 inhibits tumor growth and migration of osteosarcoma by targeting plexinA4 and CDK6
Authors: Z. S. TIAN, M. J. YAN, S. LI, D. CONG, Y. Y. WANG, Q. S. ZHU
Neoplasma Vol.69, No.4, p.993, 2022
Price: free access
[View Abstract]

Abnormal expression and clinical significance of surface receptors on natural killer cells in the peripheral blood of patients with non-small cell lung cancer
Authors: Peng-Cheng Liu, Xiao-Wen Feng, Xiao-Min Zhao, Jing Ye, Feng-Lian He, Hui Liu, Ren-Ming Li, Xue-Fu Wang, Da-Hai Zhao
Neoplasma Vol.69, No.4, p.931–939, 2022
Price: free access
[View Abstract]

LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis
Authors: Kai-Yun Chen, Shu-Guang Zhu, Ji-Wen He, Xiao-Peng Duan
Neoplasma Vol.69, No.4, p.918–930, 2022
Price: free access
[View Abstract]

SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level
Authors: Zhen Li, Dong-Ping Yu, Ning Wang, Ting Tao, Wu Luo, Hui Chen
Neoplasma Vol.69, No.4, p.909–917, 2022
Price: free access
[View Abstract]

N-type calcium channel v2.2 is a target of TCF21 in adrenocortical carcinomas
Authors: Barbara dos Santos Passaia, Jean Lucas Kremer, Maria Candida Villares Fragoso, Claudimara Ferini Pacicco Lotfi
Neoplasma Vol.69, No.4, p.899–908, 2022
Price: free access
[View Abstract]

The association of immune cell infiltration and prognostic value of tertiary lymphoid structures in gastric cancer
Authors: Ji-Shang Yu, Wei-Bin Huang, Yu-Hui Zhang, Jian Chen, Jin Li, Hua-Feng Fu, Zhe-Wei Wei, Yu-Long He
Neoplasma Vol.69, No.4, p.886–898, 2022
Price: free access
[View Abstract]

Display #  
Results 41 - 60 of 145

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.